Comparison
Abeta Amyloidosis Arctic Type C2751494 vs 2 5 Finger Cutaneous Syndactyly C4025165
Clinical comparison between Abeta Amyloidosis Arctic Type and 2 5 Finger Cutaneous Syndactyly for differential diagnosis and treatment planning.
Abeta Amyloidosis Arctic Type C2751494
Hereditary amyloidosis from APP gene mutation causing amyloid buildup in brain blood vessels. Runs in families. Managed symptomatically.
2 5 Finger Cutaneous Syndactyly C4025165
A congenital hand difference where the skin between the second and fifth fingers is joined. Surgery to separate the fingers can be performed for functional or cosmetic reasons.
6 comparison axes
Onset
Abeta Amyloidosis Arctic Type C2751494
50-65
2 5 Finger Cutaneous Syndactyly C4025165
0-0
Onset patterns differ
Severity
Abeta Amyloidosis Arctic Type C2751494
severe
2 5 Finger Cutaneous Syndactyly C4025165
mild
Different severity levels
Chronic
Abeta Amyloidosis Arctic Type C2751494
Chronic
2 5 Finger Cutaneous Syndactyly C4025165
Chronic
Differing course
Communicable
Abeta Amyloidosis Arctic Type C2751494
No
2 5 Finger Cutaneous Syndactyly C4025165
No
Different transmission
Body System
Abeta Amyloidosis Arctic Type C2751494
neurologic
2 5 Finger Cutaneous Syndactyly C4025165
musculoskeletal
Same/different system
Category
Abeta Amyloidosis Arctic Type C2751494
rare-disease
2 5 Finger Cutaneous Syndactyly C4025165
other
Different category
Bottom line
abeta-amyloidosis-arctic-type-C2751494 and 2-5-finger-cutaneous-syndactyly-C4025165 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abeta Amyloidosis Arctic Type C2751494 | 2 5 Finger Cutaneous Syndactyly C4025165 | Discriminating power |
|---|---|---|---|
| Age at recognition | Reported onset in adulthood, about ages 50–65. | Present from birth. | High |
| Main affected system | Neurologic disease from amyloid in brain blood vessels. | Musculoskeletal hand difference limited to skin joining fingers 2–5. | High |
| Functional impact | Described as severe and managed symptomatically; exact symptoms are not established here. | Described as mild; function or appearance may prompt surgery. | Moderate |
When to favor each condition
Choose Abeta Amyloidosis Arctic Type C2751494 when
Adult-onset familial neurologic illness
Fits the supplied hereditary APP-related cerebral amyloid description.
Moderate
Suspected brain-vessel amyloid disease
The source specifically describes amyloid buildup in cerebral blood vessels.
Moderate
Need for symptomatic neurologic care
Management is described as symptomatic rather than corrective surgery.
Moderate
Choose 2 5 Finger Cutaneous Syndactyly C4025165 when
Newborn or child with joined finger skin
Cutaneous syndactyly is congenital and visible on examination.
High
Function or appearance concerns
Separation surgery may be considered for functional or cosmetic reasons.
Moderate
No neurologic or familial amyloid features
The hand finding alone does not suggest Arctic-type amyloidosis.
High
How key tests differ
| Test | Abeta Amyloidosis Arctic Type C2751494 | 2 5 Finger Cutaneous Syndactyly C4025165 | Interpretation |
|---|---|---|---|
| Clinical examination | No specific bedside finding is established in the source. | Skin webbing between the second and fifth fingers is directly visible. | Examination can identify syndactyly; it cannot confirm amyloidosis. |
| Genetic evaluation | An APP mutation is the stated cause, but testing details are not supplied. | No specific genetic cause is provided. | Genetics may support the amyloid diagnosis only with clinician-directed testing. |
| Imaging or laboratory studies | No exact imaging or laboratory cutoff is established here. | Imaging may assess bones or soft tissue if surgery is planned. | Abnormal results are not diagnoses and require specialist interpretation. |
Prognosis comparison
Abeta Amyloidosis Arctic Type C2751494
- Outcome
- Chronic severe neurologic disease is described; survival and disability rates are not established.
- Factors
- Family history, APP-related disease, and symptom burden may matter.
2 5 Finger Cutaneous Syndactyly C4025165
- Outcome
- Generally a mild congenital difference; many outcomes depend on function and whether surgery is chosen.
- Factors
- Extent of skin joining, hand function, and surgical result may influence outcome.
Time frame: Amyloidosis is described from roughly ages 50–65 onward; syndactyly is lifelong from birth.
No reliable prognosis can be individualized from these sparse data.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic progression | A severe chronic neurologic course is described, without a specified complication list. No neurologic complication is described. Do not infer seizures, stroke, or mortality from the supplied coding. |
| Hand function | No hand abnormality is described. Webbing may limit independent finger movement or dexterity. Impact varies and should be assessed individually. |
| Treatment-related issues | Symptomatic care may be needed; no regimen is established here. Surgical separation can have scarring or stiffness, but rates are not supplied. Benefits and risks require surgical counseling. |
Patient education highlights
- HighDifferent conditions
One affects brain blood vessels through inherited amyloid; the other is congenital finger-skin joining.
- HighInheritance and transmission
Arctic type runs in families but is not contagious. Syndactyly is not communicable; its inheritance is not established here.
- MediumCare planning
Neurologic symptoms need clinician review. Finger separation is optional and based on function or appearance.